Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study

Abstract Background Photodynamic therapy (PDT) using 5-aminolevulinic acid (5-ALA) is a skin cancer therapy that still has limitations due to the low penetration of this drug into the skin. We have proposed in this work a delivery system for 5-ALA based on liposomes having lipid composition similar to the mammalian stratum corneum (SCLLs) in order to optimize its skin delivery in Photodynamic Therapy (PDT) of skin cancers. Methods SCLLs were obtained by reverse phase evaporation technique and size distribution of the vesicles was determinated by photon correlation spectroscopy. In vitro permeation profile was characterized using hairless mouse skin mounted in modified Franz diffusion cell. Results Size exclusion chromatography on gel filtration confirmed vesicle formation. SCLLs obtained by presented a degree of encapsulation of 5-ALA around 5.7%. A distribution of vesicle size centering at around 500 nm and 400 nm respectively for SCLLs and SCLLs containing 5-ALA was found. In vitro 5-ALA permeation study showed that SCLLs preparations presented higher skin retention significantly (p < 0.05) on the epidermis without SC + dermis, with a decreasing of skin permeation compared to aqueous solution. Conclusions The in vitro delivery performance provided by SCLLs lead to consider this systems adequate for the 5-ALA-PDT of skin cancer, since SCLLs have delivered 5-ALA to the target skin layers (viable epidermis + dermis) to be treated by topical PDT of skin cancer.

Results from the HST/COS FUV detector "lifetime move"

We describe the planning, implementation, and initial results of the first planned move of the default position of spectra on the Hubble Space Telescope's Cosmic Origins Spectrograph (COS) Far Ultraviolet (FUV) cross-delay line detector. This was motivated by the limited amount of charge that can be extracted from the microchannel plate due to gain sag at any one position. Operations at a new location began on July 23, 2012, with a shift of the spectrum by +3.5"(corresponding to ~ 41 pixels or ~ 1 mm) in a direction orthogonal to the spectral dispersion. Operation at this second "lifetime position" allows for spectra to be collected which are not affected by detector artifacts and loss of sensitivity due to gain sag. We discuss programs designed to enable operations at the new lifetime position; these include determinations of operational high voltage, measuring walk corrections and focus, confirming spectrum placement and aperture centering, and target acquisition performance. We also present results related to calibration of the new lifetime position, including measurements of spectral resolution and wavelength calibration, flux and flat field calibration, carryover of time-dependent sensitivity monitoring, and operations with the Bright Object Aperture (BOA).